FDA.reportPublic FDA data

SODIUM FORMALDEHYDE SULFOXYLATE

Substance profile for UNII X4ZGP7K714, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for SODIUM FORMALDEHYDE SULFOXYLATE
Structure render from PubChem CID 23689980

Substance Identity#

UNII
X4ZGP7K714
Preferred term
SODIUM FORMALDEHYDE SULFOXYLATE
Registry number
149-44-0
EC number
205-739-4
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
CH3O3S.Na
Chemical structure for SODIUM FORMALDEHYDE SULFOXYLATE
Structure render from PubChem CID 23689980

Chemical And Database Identifiers#

InChIKey
XWGJFPHUCFXLBL-UHFFFAOYSA-M
SMILES
[Na+].OCS([O-])=O
RxCUI
0
PubChem
23689980
NCIt
C76732
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound23689980https://pubchem.ncbi.nlm.nih.gov/compound/23689980
PubChem InChIKey SearchXWGJFPHUCFXLBL-UHFFFAOYSA-Mhttps://pubchem.ncbi.nlm.nih.gov/#query=XWGJFPHUCFXLBL-UHFFFAOYSA-M
NCI ThesaurusC76732https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C76732
FDA Substance Registration SystemX4ZGP7K714https://precision.fda.gov/uniisearch/srs/unii/X4ZGP7K714
European Community number205-739-4https://commonchemistry.cas.org/results?q=205-739-4

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
sodium formaldehyde sulfoxylateINACTIVE INGREDIENTX4ZGP7K714RIFADIN (RIFAMPIN) CAPSULE RIFADIN IV (RIFAMPIN) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SANOFI-AVENTIS U.S. LLC]9
SODIUM FORMALDEHYDE SULFOXYLATEINACTIVE INGREDIENTX4ZGP7K714RIFAMPIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC]6
SODIUM FORMALDEHYDE SULFOXYLATEINACTIVE INGREDIENTX4ZGP7K714RIFAMPIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HERITAGE PHARMACEUTICALS INC.]5
Sodium formaldehyde SulfoxylateINACTIVE INGREDIENTX4ZGP7K714BANAMINE (FLUNIXIN MEGLUMINE) INJECTION [SCHERING CORPORATION]3
SODIUM FORMALDEHYDE SULFOXYLATEINACTIVE INGREDIENTX4ZGP7K714RIFAMPIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [PFIZER LABORATORIES DIV PFIZER INC]3
sodium formaldehyde sulfoxylateINACTIVE INGREDIENTX4ZGP7K714300 PRO LA (OXYTETRACYCLINE) INJECTION, SOLUTION [NORBROOK LABORATORIES LIMITED]2
sodium formaldehyde sulfoxylateINACTIVE INGREDIENTX4ZGP7K714FLUNIXIN-S (FLUNIXIN MEGLUMINE) INJECTION, SOLUTION [NORBROOK LABORATORIES LIMITED]2
SODIUM FORMALDEHYDE SULFOXYLATEINACTIVE INGREDIENTX4ZGP7K714MORPHINE SULFATE INJECTION [WEST-WARD PHARMACEUTICAL CORP.]2
sodium formaldehyde sulfoxylateINACTIVE INGREDIENTX4ZGP7K714NOROCILLIN (PENICILLIN G PROCAINE) INJECTION, SUSPENSION [NORBROOK LABORATORIES LIMITED]2
sodium formaldehyde sulfoxylateINACTIVE INGREDIENTX4ZGP7K714BACTRACILLIN G (PENICILLIN G PROCAINE) INJECTION, SUSPENSION [ASPEN VETERINARY]1
SODIUM FORMALDEHYDE SULFOXYLATEINACTIVE INGREDIENTX4ZGP7K714BIO-MYCIN 200 (OXYTETRACYCLINE) INJECTION [BOEHRINGER INGELHEIM VETMEDICA, INC.]1
sodium formaldehyde sulfoxylateINACTIVE INGREDIENTX4ZGP7K714HEXASOL (OXYTETRACYCLINE, FLUNIXIN MEGLUMINE) INJECTION, SOLUTION [NORBROOK LABORATORIES LIMITED]1
sodium formaldehyde sulfoxylateINACTIVE INGREDIENTX4ZGP7K714LIQUAMYCIN LA-200 (OXYTETRACYCLINE) INJECTION, SOLUTION [ZOETIS INC.]1
sodium formaldehyde sulfoxylateINACTIVE INGREDIENTX4ZGP7K714NOROMYCIN 300 LA (OXYTETRACYCLINE) INJECTION, SOLUTION [NORBROOK LABORATORIES LIMITED]1
Sodium Formaldehyde SulfoxylateINACTIVE INGREDIENTX4ZGP7K714OXYTETRACYCLINE INJECTION 200 (OXYTETRACYCLINE) INJECTION, SOLUTION [NORBROOK LABORATORIES LIMITED]1
SODIUM FORMALDEHYDE SULFOXYLATEINACTIVE INGREDIENTX4ZGP7K714RIFAMPIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [FRESENIUS KABI USA, LLC]1
SODIUM FORMALDEHYDE SULFOXYLATEINACTIVE INGREDIENTX4ZGP7K714RIFAMPIN INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [MYLAN INSTITUTIONAL LLC ]1
SODIUM FORMALDEHYDE SULFOXYLATEINACTIVE INGREDIENTX4ZGP7K714SULFAMED (SULFADIMETHOXINE) INJECTION [BIMEDA, INC. DIVISION OF CROSS VETPHARM GROUP]1